Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Revue Medicale Suisse
|
February 26, 2009
[Psychiatry]
Nicola Gervasoni, Christian Bryois, Rémy Barbe, et al.
Revue Medicale Suisse
|
March 4, 2008
[Trends in psychiatry]
Nicola Gervasoni, Remy Barbe, Christian Bryois, et al.
Pharmacological Research
|
December 17, 2008
Is there a place for tricyclic antidepressants and subsequent augmentation strategies in obtaining remission for patients with treatment resistant depression?
Nicola Gervasoni, Jean-Michel Aubry, Marianne Gex-Fabry, et al.
Biological Psychiatry
|
April 30, 2005
Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity
Félicien Karege, Guido Bondolfi, Nicola Gervasoni, et al.
Journal of Affective Disorders
|
August 2, 2005
Screening for bipolar disorders using a French version of the Mood Disorder Questionnaire (MDQ)
Béatrice Weber Rouget, Nicola Gervasoni, Vesselin Dubuis, et al.
Neuropsychobiology
|
May 18, 2005
Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode
Nicola Gervasoni, Jean-Michel Aubry, Guido Bondolfi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
March 31, 2007
Time course of response to paroxetine: influence of plasma level
Marianne Gex-Fabry, Nicola Gervasoni, Chin B Eap, et al.
Nordic Journal of Psychiatry
|
February 20, 2010
Early telephone intervention for psychiatric outpatients starting antidepressant treatment
Nicola Gervasoni, Pascaline Legendre-Simon, Jean-Michel Aubry, et al.
Journal of Psychiatric Research
|
September 8, 2006
The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients
Jean-Michel Aubry, Nicola Gervasoni, Christian Osiek, et al.
Therapeutic Drug Monitoring
|
July 22, 2008
CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response
Marianne Gex-Fabry, Chin B Eap, Beatrice Oneda, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Revue Medicale Suisse
|
February 26, 2009
[Psychiatry]
Nicola Gervasoni, Christian Bryois, Rémy Barbe, et al.
Revue Medicale Suisse
|
March 4, 2008
[Trends in psychiatry]
Nicola Gervasoni, Remy Barbe, Christian Bryois, et al.
Pharmacological Research
|
December 17, 2008
Is there a place for tricyclic antidepressants and subsequent augmentation strategies in obtaining remission for patients with treatment resistant depression?
Nicola Gervasoni, Jean-Michel Aubry, Marianne Gex-Fabry, et al.
Biological Psychiatry
|
April 30, 2005
Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity
Félicien Karege, Guido Bondolfi, Nicola Gervasoni, et al.
Journal of Affective Disorders
|
August 2, 2005
Screening for bipolar disorders using a French version of the Mood Disorder Questionnaire (MDQ)
Béatrice Weber Rouget, Nicola Gervasoni, Vesselin Dubuis, et al.
Neuropsychobiology
|
May 18, 2005
Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode
Nicola Gervasoni, Jean-Michel Aubry, Guido Bondolfi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
March 31, 2007
Time course of response to paroxetine: influence of plasma level
Marianne Gex-Fabry, Nicola Gervasoni, Chin B Eap, et al.
Nordic Journal of Psychiatry
|
February 20, 2010
Early telephone intervention for psychiatric outpatients starting antidepressant treatment
Nicola Gervasoni, Pascaline Legendre-Simon, Jean-Michel Aubry, et al.
Journal of Psychiatric Research
|
September 8, 2006
The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients
Jean-Michel Aubry, Nicola Gervasoni, Christian Osiek, et al.
Therapeutic Drug Monitoring
|
July 22, 2008
CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response
Marianne Gex-Fabry, Chin B Eap, Beatrice Oneda, et al.
Page
of 2